{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 interacts with the E3 ligase Parkin (PARK2) through its UIM domains, which hampers the auto-ubiquitination of Parkin.",
  "functions": [
    {
      "function": "Parkin E3 Ligase Activity",
      "arrow": "inhibits",
      "cellular_process": "ATXN3 directly interacts with the E3 ubiquitin ligase Parkin (PARK2). This interaction is enhanced by Parkin's autoubiquitination. ATXN3 does not deubiquitinate pre-existing ubiquitin chains on Parkin but rather interferes with the attachment of new ubiquitin molecules.",
      "effect_description": "ATXN3 stabilizes the complex between Parkin and its E2 ubiquitin-conjugating enzyme, which impedes the efficient charging of the E2 enzyme with ubiquitin. This ultimately hampers Parkin's auto-ubiquitination, a process required for its full E3 ligase activity, thereby reducing the ubiquitination of Parkin's substrates. PolyQ-expanded ATXN3 is more effective at deubiquitinating Parkin and promotes its clearance through autophagy.",
      "biological_consequence": [
        "ATXN3 binds to auto-ubiquitinated Parkin → ATXN3 stabilizes the Parkin-E2 enzyme complex → Charging of the E2 enzyme with ubiquitin is impeded → Parkin auto-ubiquitination is reduced → Parkin E3 ligase activity is hampered → Ubiquitination of Parkin substrates is decreased."
      ],
      "specific_effects": [
        "Directly binds to Parkin, an interaction enhanced by Parkin self-ubiquitination.",
        "Interferes with the attachment of ubiquitin onto Parkin during conjugation.",
        "Stabilizes the complex between Parkin and the E2 ubiquitin-conjugating enzyme.",
        "PolyQ-expanded ATXN3 enhances the clearance of Parkin via the autophagy pathway."
      ],
      "evidence": [
        {
          "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
          "journal": "Human Molecular Genetics",
          "year": 2011,
          "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells. Compared with wild-type ataxin-3, MJD-linked polyQ-expanded mutant ataxin-3 is more active...Remarkably, mutant but not wild-type ataxin-3 promotes the clearance of parkin via the autophagy pathway.",
          "pmid": "20940148"
        },
        {
          "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
          "journal": "The Journal of Biological Chemistry",
          "year": 2012,
          "relevant_quote": "We report here that ataxin-3 interferes with the attachment of ubiquitin (Ub) onto parkin in real-time during conjugation but is unable to hydrolyze previously assembled parkin-Ub conjugates. The mechanism involves an ataxin-3-dependent stabilization of the complex between parkin and the E2 Ub-conjugating enzyme, which impedes the efficient charging of the E2 with Ub.",
          "pmid": "22081612"
        }
      ],
      "pathway": {
        "name": "Ubiquitin-Proteasome System",
        "canonical_name": "Proteasomal Degradation",
        "ontology_id": "GO:0010498",
        "ontology_source": "GO",
        "confidence": 0.8
      },
      "pmids": [
        "20940148",
        "22081612"
      ],
      "interaction_effect": "inhibits",
      "interaction_direction": "main_to_primary",
      "function_effect": "inhibition"
    }
  ],
  "arrow": "inhibits",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "inhibits"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "ATXN3 directly interacts with the E3 ubiquitin ligase Parkin (PARK2). This interaction is enhanced by Parkin's autoubiquitination. ATXN3 does not deubiquitinate pre-existing ubiquitin chains on Parkin but rather interferes with the attachment of new ubiquitin molecules.",
  "effect": "ATXN3 stabilizes the complex between Parkin and its E2 ubiquitin-conjugating enzyme, which impedes the efficient charging of the E2 enzyme with ubiquitin. This ultimately hampers Parkin's auto-ubiquitination, a process required for its full E3 ligase activity, thereby reducing the ubiquitination of Parkin's substrates. PolyQ-expanded ATXN3 is more effective at deubiquitinating Parkin and promotes its clearance through autophagy.",
  "summary": "ATXN3 inhibits PARK2 to modulate parkin e3 ligase activity, ultimately affecting ubiquitination of parkin substrates is decreased.",
  "evidence": [
    {
      "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
      "journal": "Human Molecular Genetics",
      "year": 2011,
      "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells. Compared with wild-type ataxin-3, MJD-linked polyQ-expanded mutant ataxin-3 is more active...Remarkably, mutant but not wild-type ataxin-3 promotes the clearance of parkin via the autophagy pathway."
    },
    {
      "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
      "journal": "The Journal of Biological Chemistry",
      "year": 2012,
      "relevant_quote": "We report here that ataxin-3 interferes with the attachment of ubiquitin (Ub) onto parkin in real-time during conjugation but is unable to hydrolyze previously assembled parkin-Ub conjugates. The mechanism involves an ataxin-3-dependent stabilization of the complex between parkin and the E2 Ub-conjugating enzyme, which impedes the efficient charging of the E2 with Ub."
    }
  ],
  "pathways": [
    {
      "name": "Ubiquitin-Proteasome System",
      "canonical_name": "Proteasomal Degradation",
      "ontology_id": "GO:0010498",
      "ontology_source": "GO",
      "confidence": 0.8
    }
  ],
  "interaction_effect": "inhibition",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 1
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --inhibits--> PARK2:",
  "protein_a": "PARK2",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-30T15:37:50.061531Z",
  "last_updated": "2025-11-30T15:37:50.061531Z"
}